Found: 148
Select item for more details and to access through your institution.
Disease-associated functions of IL-33: the new kid in the IL-1 family.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Cytokines in the pathogenesis of rheumatoid arthritis.
- Published in:
- Nature Reviews Immunology, 2007, v. 7, n. 6, p. 429, doi. 10.1038/nri2094
- By:
- Publication type:
- Article
MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 11, p. 2056, doi. 10.1093/rheumatology/kew272
- By:
- Publication type:
- Article
Assessment of murine collagen-induced arthritis by longitudinal non-invasive duplexed molecular optical imaging.
- Published in:
- Rheumatology, 2016, v. 55, n. 3, p. 564, doi. 10.1093/rheumatology/kev361
- By:
- Publication type:
- Article
Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation.
- Published in:
- Rheumatology, 2016, v. 55, n. 1, p. 120, doi. 10.1093/rheumatology/kev245
- By:
- Publication type:
- Article
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4+ T cell-priming capacity of dendritic cells.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4+ T cell-priming capacity of dendritic cells.
- Published in:
- Rheumatology, 2015, v. 54, n. 1, p. 169, doi. 10.1093/rheumatology/keu273
- By:
- Publication type:
- Article
Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study.
- Published in:
- Rheumatology, 2014, v. 53, n. 4, p. 737, doi. 10.1093/rheumatology/ket435
- By:
- Publication type:
- Article
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
- Published in:
- Rheumatology, 2013, v. 52, n. 10, p. 1754, doi. 10.1093/rheumatology/ket187
- By:
- Publication type:
- Article
Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis.
- Published in:
- Rheumatology, 2013, v. 52, n. 9, p. 1556, doi. 10.1093/rheumatology/ket225
- By:
- Publication type:
- Article
Alarmins in tendinopathy: unravelling new mechanisms in a common disease.
- Published in:
- Rheumatology, 2013, v. 52, n. 5, p. 769, doi. 10.1093/rheumatology/kes409
- By:
- Publication type:
- Article
Markedly increased IL-18 liver expression in adult-onset Still’s disease-related hepatitis.
- Published in:
- Rheumatology, 2011, v. 50, n. 4, p. 776, doi. 10.1093/rheumatology/keq397
- By:
- Publication type:
- Article
Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?
- Published in:
- Journal of Foot & Ankle Research, 2010, v. 3, p. 8, doi. 10.1186/1757-1146-3-8
- By:
- Publication type:
- Article
Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain.
- Published in:
- FASEB Journal, 2016, v. 30, n. 1, p. 54, doi. 10.1096/fj.14-267146
- By:
- Publication type:
- Article
Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 1, p. 1, doi. 10.1080/14397595.2021.1902617
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Translational Sports Medicine, 2021, v. 4, n. 2, p. i, doi. 10.1002/tsm2.241
- By:
- Publication type:
- Article
Stromal "activation" markers do not confer pathogenic activity in tendinopathy.
- Published in:
- Translational Sports Medicine, 2021, v. 4, n. 2, p. 268, doi. 10.1002/tsm2.204
- By:
- Publication type:
- Article
S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37684-3
- By:
- Publication type:
- Article
Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 218, doi. 10.1093/rheumatology/kead195
- By:
- Publication type:
- Article
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis.
- Published in:
- Rheumatology, 2023, v. 62, n. 4, p. 1417, doi. 10.1093/rheumatology/keac500
- By:
- Publication type:
- Article
review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition.
- Published in:
- Rheumatology, 2022, v. 61, n. 5, p. 1783, doi. 10.1093/rheumatology/keab740
- By:
- Publication type:
- Article
Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study.
- Published in:
- Rheumatology, 2022, v. 61, n. 3, p. 1026, doi. 10.1093/rheumatology/keab474
- By:
- Publication type:
- Article
Apremilast inhibits inflammatory osteoclastogenesis.
- Published in:
- Rheumatology, 2022, v. 61, n. 1, p. 452, doi. 10.1093/rheumatology/keab315
- By:
- Publication type:
- Article
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5337, doi. 10.1093/rheumatology/keab285
- By:
- Publication type:
- Article
IL-23 orchestrating immune cell activation in arthritis.
- Published in:
- Rheumatology, 2021, v. 60, p. iv4, doi. 10.1093/rheumatology/keab266
- By:
- Publication type:
- Article
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2109, doi. 10.1093/rheumatology/keab119
- By:
- Publication type:
- Article
Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity – a cross-sectional study.
- Published in:
- Rheumatology, 2021, v. 60, n. 4, p. 1858, doi. 10.1093/rheumatology/keaa604
- By:
- Publication type:
- Article
The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion.
- Published in:
- Rheumatology, 2020, v. 59, n. 4, p. 869, doi. 10.1093/rheumatology/kez378
- By:
- Publication type:
- Article
Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank.
- Published in:
- Rheumatology, 2019, v. 58, n. 12, p. 2137, doi. 10.1093/rheumatology/kez192
- By:
- Publication type:
- Article
263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
257 Secukinumab demonstrates a consistent safety profile with up to 5 years' treatment in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
256 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 4-year results from the Phase 3 FUTURE 2 study.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
254 Impact of secukinumab treatment on psoriatic arthritis patients with or without enthesitis at baseline: pooled data from FUTURE 2 AND FUTURE 3 Phase 3 studies.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.
- Published in:
- Rheumatology, 2019, v. 58, p. i43, doi. 10.1093/rheumatology/key276
- By:
- Publication type:
- Article
rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 197, doi. 10.1093/rheumatology/key070
- By:
- Publication type:
- Article
Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment.
- Published in:
- Rheumatology, 2018, v. 57, n. 12, p. 2149, doi. 10.1093/rheumatology/key222
- By:
- Publication type:
- Article
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
- Published in:
- Rheumatology, 2017, v. 56, n. 11, p. 1993, doi. 10.1093/rheumatology/kex301
- By:
- Publication type:
- Article
Castleman disease and lymphocytic interstitial pneumonia: a complex diagnostic and management challenge.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis.
- Published in:
- Nature Communications, 2016, v. 7, n. 9, p. 12970, doi. 10.1038/ncomms12970
- By:
- Publication type:
- Article
MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease.
- Published in:
- Nature Communications, 2015, v. 6, n. 4, p. 6774, doi. 10.1038/ncomms7774
- By:
- Publication type:
- Article
Vancomycin Wrap for Anterior Cruciate Ligament Surgery: Molecular Insights.
- Published in:
- American Journal of Sports Medicine, 2021, v. 49, n. 2, p. 426, doi. 10.1177/0363546520981570
- By:
- Publication type:
- Article
Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2021, p. 1, doi. 10.1177/1759720X211043977
- By:
- Publication type:
- Article
Influence of periodontal disease , Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres.
- Published in:
- Journal of Clinical Periodontology, 2013, v. 40, n. 10, p. 907, doi. 10.1111/jcpe.12138
- By:
- Publication type:
- Article
Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?
- Published in:
- Podiatry Review, 2011, v. 68, n. 6, p. 16
- By:
- Publication type:
- Article
Psoriatic arthritis -- expanding options, exciting times?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis.
- Published in:
- 2013
- By:
- Publication type:
- journal article